Switching from Vyvanse 50 mg to Focalin (Dexmethylphenidate) in Adults
Start with Focalin XR 10 mg once daily in the morning, then titrate upward in 10 mg increments weekly based on symptom response, up to a maximum of 40 mg daily. 1
Rationale for Starting Dose
When switching from Vyvanse (lisdexamfetamine) 50 mg to dexmethylphenidate, you're transitioning from an amphetamine-based stimulant to a methylphenidate-based stimulant. There is no direct dose conversion between these two medication classes, so you must start fresh with the FDA-recommended initial dosing for adults switching to a new stimulant class.
The FDA label for Focalin XR specifies that adults new to methylphenidate should start at 10 mg once daily 1. While your patient isn't technically "new" to stimulants, they are new to the methylphenidate class, making this the appropriate starting point.
Titration Schedule
- Week 1: Start Focalin XR 10 mg once daily in the morning
- Week 2 onward: Increase by 10 mg increments weekly if symptom control is inadequate 1
- Maximum dose: 40 mg daily for adults 1
This weekly titration allows you to assess both efficacy and tolerability at each dose level before advancing. Monitor ADHD symptoms and side effects (particularly appetite suppression, insomnia, blood pressure, and pulse) at each increment 2.
Key Clinical Considerations
Expect a transition period with potentially suboptimal symptom control. Vyvanse 50 mg represents a moderate-to-high therapeutic dose of an amphetamine prodrug with 13-hour duration. Starting Focalin XR at 10 mg will likely provide less robust initial coverage, but this conservative approach minimizes the risk of adverse effects from the new medication class.
The pharmacokinetic profiles differ substantially:
- Vyvanse has a smooth, prolonged release lasting up to 13 hours
- Focalin XR has a bimodal release mimicking two immediate-release doses 4 hours apart, with duration of 10-12 hours 3, 4
Common pitfalls to avoid:
- Don't assume equivalent dosing between amphetamine and methylphenidate classes—they have different potency profiles
- Don't rush titration; weekly increments allow proper assessment of each dose level 2
- Don't exceed 40 mg daily in adults without clear documentation that lower doses failed and higher doses produce no adverse effects 1
Monitoring Requirements
- Baseline: Blood pressure, pulse, weight before switching 2
- During titration: Weekly phone contact or visits to assess symptom response and side effects 2
- Maintenance: Quarterly blood pressure and pulse checks once stable dose achieved 2
Alternative Formulation Option
If the patient cannot swallow capsules, Focalin XR capsules can be opened and sprinkled on applesauce 1, 5. This maintains the extended-release properties while improving administration ease.
The immediate-release formulation (Focalin IR) could be considered if more flexible dosing is needed, starting at 5 mg twice daily and titrating in 2.5-5 mg increments 2, though this requires midday dosing which many adults find inconvenient.
Expected Timeline to Therapeutic Effect
Most patients reach an optimal dose within 2-4 weeks of titration 2. If adequate symptom control isn't achieved by 30-40 mg daily, consider that methylphenidate-based medications may not be the right class for this patient, and switching back to an amphetamine-based alternative or trying atomoxetine may be warranted 6.